Drozdov et al., 2017 - Google Patents
Magnetic thrombolytic ceramic nanoparticlesDrozdov et al., 2017
- Document ID
- 2812787359283947080
- Author
- Drozdov A
- Vinogradov V
- Publication year
- Publication venue
- Materials Today: Proceedings
External Links
Snippet
The present study is devoted to the development of a new class of thrombolytic systems– magnetic thrombolytic ceramic nanoparticles. Indirect plasminogen activator, streptokinase, was entrapped into magnetite sol-gel matrix to produce magnetically-targetable solid-state …
- 230000002537 thrombolytic 0 title abstract description 27
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chapurina et al. | Streptokinase@ alumina nanoparticles as a promising thrombolytic colloid with prolonged action | |
| Shabanova et al. | Thrombin@ Fe3O4 nanoparticles for use as a hemostatic agent in internal bleeding | |
| US20220153589A1 (en) | Identification and optimization of carbon radicals on hydrated graphene oxide for ubiquitous antibacterial coatings | |
| Hassanpour et al. | Thrombolytic agents: nanocarriers in controlled release | |
| Nordström et al. | Membrane interactions of microgels as carriers of antimicrobial peptides | |
| Bi et al. | Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis | |
| Hu et al. | Magnetically active Fe3O4 nanorods loaded with tissue plasminogen activator for enhanced thrombolysis | |
| Du et al. | Dual drug-loaded hydrogels with pH-responsive and antibacterial activity for skin wound dressing | |
| Drozdov et al. | Leach-proof magnetic thrombolytic nanoparticles and coatings of enhanced activity | |
| Chen et al. | Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator | |
| US7855180B2 (en) | Structure and method for releasing substance therefrom | |
| JPH07503454A (en) | Fibrinolytic and fibrinolytic treatment with plasmin | |
| US7670623B2 (en) | Hemostatic composition | |
| US20060104970A1 (en) | Biological glue based on thrombin-conjugated nanoparticles | |
| Xie et al. | Photothermal hydrogels for promoting infected wound healing | |
| Wu et al. | Construction of polylysine dendrimer nanocomposites carrying nattokinase and their application in thrombolysis | |
| Asare et al. | Nanotechnologies for control of pathogenic microbial biofilms | |
| Li et al. | CaCO 3 nanoparticles pH-sensitively induce blood coagulation as a potential strategy for starving tumor therapy | |
| Wang et al. | Bioactive anti-inflammatory thermocatalytic nanometal-polyphenol polypeptide scaffolds for MRSA-infection/tumor postsurgical tissue repair | |
| Nguyen et al. | Preparation and in vitro evaluation of FGF-2 incorporated carboxymethyl chitosan nanoparticles | |
| Tadayon et al. | Targeted thrombolysis of tissue plasminogen activator and streptokinase with extracellular biosynthesis nanoparticles using optimized Streptococcus equi supernatant | |
| Hunt et al. | Simplified recombinant plasmin: production and functional comparison of a novel thrombolytic molecule with plasma-derived plasmin | |
| Zhu et al. | Macrophage polarization induced by bacteria‐responsive antibiotic‐loaded Nanozymes for multidrug resistance‐bacterial infections management | |
| Kuznetsov et al. | Correlation of the coagulation rates and toxicity of biocompatible ferromagnetic microparticles | |
| Drozdov et al. | Magnetic thrombolytic ceramic nanoparticles |